Tembisa Hospital CEO rubbishes health ombud report on Shonisani Leshole
SA to receive first batch of COVID-19 vaccine on Monday
753 people succumb to COVID-19 and 7,070 infections recorded
ConCourt orders Zuma to appear at Zondo commision, must obey all directives
Wine producers set to challenge alcohol sale ban in High Court
Zondo inquiry continues to hear astonishing testimony about SSA dealings
Windhoek beer ad banned in SA for entrenching 'toxic masculinity'
'The Great African IP Address Heist' - 4m stolen, most from SA organisations
Would you invest in a blank cheque company?
New series of free online courses to help young people boost employment chances
[EXPLAINED] Can your employer force you to take a Covid-19 vaccine?
Sello Maake kaNcube has the perfect playlist for you on Spotify
Swallows remain undefeated as Nyatama scores late equaliser against Sundowns
Ultramarathons are popular – but are they good for you?
Kaizer Chiefs’ Johannes ‘Ryder’ Mofokeng dies
[WATCH] Land Rover pulling transporter carrying 7 SUV's goes viral
[WATCH] Woman goes viral after leaving toy on bookshelf while being interviewed
[WATCH] Man rescuing dog from raging river goes viral
[VIDEO] Ramaphosa urges rich countries to release 'hoarded' vaccines
Vaccine nationalism a concern, Ramaphosa tells WEF
Fixing “the Eskom problem” is going to require a serious restructure
Seychelles President hopes to vaccinate 70% of nation's population by mid-March
Uganda elections: People suspect vote rigging because of internet shutdown
10 predictions for South African fintech in 2021 – the future arrived early
How the Putins and Trumps of the world weaponise our perception of reality
New restaurant laws: 'Don’t rush to comply. It’s being challenged'
Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
JSE-listed Aspen Pharmacare has struck a deal with US multinational Johnson & Johnson to commercially manufacture its vaccine candidate.
Johnson & Johnson’s “Ad26.COV2-S” vaccine is undergoing clinical trials.
Aspen Pharmacare will make the vaccines at an existing factory in Port Elizabeth if trials are successful and manufacturing terms are finalised.
The facility is capable of making 300 million vaccine doses per year.
Aspen Pharmacare’s share price was up 11.45% on Monday.
The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare.
Johnson & Johnson’s is a $400 billion company… We’re well-positioned… The tech transfer – we’ve started the process…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson… we like their candidate. You only need one shot… and a fridge… They’ve got 60 000 people in their Phase-3 trial…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson promised universal access…
Stephen Saad, CEO - Aspen Pharmacare
We’ll be ready to put a vaccine into the world by March or April next year…
Stephen Saad, CEO - Aspen Pharmacare
Listen to the interview in the audio below.
Copyright : https://www.123rf.com/license.php#standardSource : https://www.123rf.com/photo_53976118_little-happy-girl-get-an-injection-vaccination.html?term=vaccine%2Bsmile&vti=mpp4sbopzossai9spw-1-1
More from MyMoney Online
Economy in 2021: 'Expect a better year for South African assets'
An economist expects China growth at 9.5%, US money-printing, rising metal prices and trade- and current-account surpluses in SA.
Read More
Retirement funds in SA are changing – new laws come into effect on 1 March 2021
Bruce Whitfield asks personal finance advisor Warren Ingram to explain in detail the new laws affecting provident funds.
Read More
How to buy your very first share – even if you have mere cents to invest
You can buy R1 (or even one cent) worth of shares. "The key to getting started is to get started," says Charles Savage.
Read More
Buying a new car may be possible – even if you can’t afford the monthly payments
Need new wheels? WesBank’s Lebogang Goaaketse discusses a popular method for making repayments more affordable.
Read More
Buy hugely discounted properties (up to 70% off) on auction right now
Distressed properties on auction are going for a song. Bruce Whitfield interviews property economist Francois Viruly.
Read More
Free Covid-19 vaccine for all medical aid members – Discovery CEO
"It’s mandatory for medical schemes to pay for for the Covid-19 vaccine," says Dr Ryan Noach, CEO at Discovery Health.
Read More
Vaccine optimism is priced in – asset manager
Investors are getting ahead of themselves, warns Pieter Hundersmarck, a fund manager at Flagship Asset Management.
Read More
Need new wheels? Car subscriptions at a monthly fee have arrived in South Africa
Bruce Whitfield interviews Tinashe Ruzane of FlexClub, where you can choose from a variety of car subscriptions for a monthly fee.
Read More
Naspers-owned Prosus (owner of Tencent) starts JSE's largest share buyback ever
The Money Show’s Bruce Whitfield interviews Basil Sgourdos, CFO at Naspers.
Read More
Pepkor Holdings profits fall 34% but gains 'significant' market share
The Money Show’s Bruce Whitfield interviews Leon Lourens, CEO at Pepkor Holdings.
Read More
Highlights